Treatment strategy for locally advanced liver cancer via novel tri-modality therapy

byThe University of Hong KongCredit: Pixabay/CC0 Public DomainA pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of C

Updated on: January 15,2024

Treatment strategy for locally advanced liver cancer via novel tri-modality therapy

byThe University of Hong KongCredit: Pixabay/CC0 Public DomainA pioneering phase II clinical study on tri-modality therapy (START-FIT), conducted by the Department of Surgery and Department of C

Updated on:January 15,2024

Treatment beneficial for nonagenarians with lung cancer

(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit for stage I patients, according to a st

Updated on: April 10,2024

Treatment beneficial for nonagenarians with lung cancer

(HealthDay)—Receiving treatment is associated with better survival for nonagenarians with non-small cell lung cancer (NSCLC), with the greatest survival benefit for stage I patients, according to a st

Updated on:April 10,2024

Long exposure to protein inhibitor may be key to more effective chemotherapy for cancer

by Southern Methodist UniversityLong exposure to P-gp inhibitor and chemotherapy decreased cancer cell survival, as assessed by colony formation. Credit: SMUResearchers at SMU's Center for Dr

Updated on: April 18,2024

Long exposure to protein inhibitor may be key to more effective chemotherapy for cancer

by Southern Methodist UniversityLong exposure to P-gp inhibitor and chemotherapy decreased cancer cell survival, as assessed by colony formation. Credit: SMUResearchers at SMU's Center for Dr

Updated on:April 18,2024

A simple text could make the difference between life and death

by University of South AustraliaCredit: CC0 Public DomainA Ph.D. researcher from the University of South Australia is testing whether smartphone text messages can encourage cancer patients to tak

Updated on: May 23,2024

A simple text could make the difference between life and death

by University of South AustraliaCredit: CC0 Public DomainA Ph.D. researcher from the University of South Australia is testing whether smartphone text messages can encourage cancer patients to tak

Updated on:May 23,2024

Two for the price of one: Mechanistic insights lead to drug repositioning

by University of TsukubaMolecular mechanism at a glance. SFN binds with SKP1 to sequester it in cytoplasm,resulting in the obstruction of SCFFBW7 598 complex formation. Oncoproteins including cyc

Updated on: May 23,2024

Two for the price of one: Mechanistic insights lead to drug repositioning

by University of TsukubaMolecular mechanism at a glance. SFN binds with SKP1 to sequester it in cytoplasm,resulting in the obstruction of SCFFBW7 598 complex formation. Oncoproteins including cyc

Updated on:May 23,2024

Researchers take new AI approach to analyzing tumors

by Karolinska InstitutetIdeas from community ecology can complement clustering-based approaches in interpreting multiplex histology data.a–cClustering can identify the cellular and ph

Updated on: June 24,2024

Researchers take new AI approach to analyzing tumors

by Karolinska InstitutetIdeas from community ecology can complement clustering-based approaches in interpreting multiplex histology data.a–cClustering can identify the cellular and ph

Updated on:June 24,2024

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on: May 11,2024

When should NHS contact patients over faulty genes?

by University of ExeterCredit: CC0 Public DomainThe NHS and health services worldwide need to develop policies on when patients should be "re-contacted" about faulty genes, as the curre

Updated on:May 11,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on: January 12,2024

New study indicates treatment patterns, not genetics, drive prostate cancer disparities

by Sylvester Comprehensive Cancer CenterOverview of study design and overall genomic landscape (A) Study overview. The study comprised 11 741 patients with prostate cancer who underwent CGP to assess

Updated on:January 12,2024

Researchers relate amplification of chromosomal region with resistance to chemotherapeutic drug in breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteEmergence of docetaxel resistance. Credit: Eva González-SuárezResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), with the part

Updated on: June 15,2024

Researchers relate amplification of chromosomal region with resistance to chemotherapeutic drug in breast cancer

by IDIBELL-Bellvitge Biomedical Research InstituteEmergence of docetaxel resistance. Credit: Eva González-SuárezResearchers at the Bellvitge Biomedical Research Institute (IDIBELL), with the part

Updated on:June 15,2024

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

Updated on: January 11,2024

New reports examine COVID's radiotherapy interruption implications

by University of Tennessee Health Science Center(A-D) Major radiation therapy (RT) interruption rates before and during the pandemic mapped by ZIP code across the metropolitan region by race and insur

Updated on:January 11,2024

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

by Society of Nuclear MedicineA radiotheranostic platform that employs a MUC16-targeting humanized antibody, huAR9.6. Ovarian cancer cells that express hypoglycosylated MUC16 residues are detecte

Updated on: April 06,2024

Novel theranostic tool allows for noninvasive identification and treatment of ovarian cancer

by Society of Nuclear MedicineA radiotheranostic platform that employs a MUC16-targeting humanized antibody, huAR9.6. Ovarian cancer cells that express hypoglycosylated MUC16 residues are detecte

Updated on:April 06,2024

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on: January 22,2024

Experts boost activity of potential therapeutic target in triple-negative breast cancer

by Diana Yates,University of Illinois at Urbana-ChampaignCredit: Unsplash/CC0 Public DomainLess than 20% of diagnosed breast cancers are designated "triple-negative," lacking three typ

Updated on:January 22,2024